Saturday, April 18, 2026
Newsletter About
Business & Finance

Lilly's obesity pill helps reduce cardiovascular risks in late-stage trial

In the study of more than 2,700 adults, patients taking Foundayo had a 16% lower risk of heart attack, stroke or cardiovascular death.

This article was originally published by CNBC Top News and is republished here under license.

In the study of more than 2,700 adults, patients taking Foundayo had a 16% lower risk of heart attack, stroke or cardiovascular death.

More in Business & Finance

View All →

Leave a Reply

Discover more from The Meridian Review

Subscribe now to keep reading and get access to the full archive.

Continue reading